Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
MNKD
MNKD
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
MNKD News
MannKind Presents New Data on Afrezza at Diabetes Conference
1d ago
Newsfilter
MannKind Corp Reports Record Q4 Revenue and Strategic Developments
4d ago
Yahoo Finance
MannKind Corporation Settles Remaining Convertible Notes
4d ago
Newsfilter
MannKind Reports 2025 Financial Results with Strong Sales Growth
Feb 27 2026
Benzinga
MannKind's Earnings Miss Expectations, Stock Drops
Feb 27 2026
Fool
MannKind Reports Mixed Earnings, Stock Drops Over 7%
Feb 27 2026
NASDAQ.COM
MannKind Corporation Reports Strong Q4 2025 Earnings and Growth Strategy
Feb 26 2026
seekingalpha
MannKind Shares Plummet to New 52-Week Low Following Earnings Miss
Feb 26 2026
seekingalpha
MannKind Q4 Earnings Beat Expectations with Revenue Growth
Feb 26 2026
seekingalpha
United Therapeutics' New Drug Plans Pressure Partner and Rival Stocks
Feb 25 2026
seekingalpha
MannKind Faces Uncertainty Over Tyvaso DPI Royalties
Feb 25 2026
stocktwits
MannKind to Announce Q4 Earnings on February 26
Feb 25 2026
seekingalpha
MannKind Launches Pediatric Diabetes Clinical Study for Afrezza
Feb 09 2026
Newsfilter
Longevity Infrastructure Market Undergoes Structural Reset
Jan 29 2026
PRnewswire
Global Capital Shifts to Longevity Infrastructure Valued at $27 Trillion
Jan 29 2026
Newsfilter
Avant Technologies Leads Transformation in Healthcare Market
Jan 26 2026
PRnewswire
Show More News
